Curcumin, a compound derived from turmeric, is a potent inhibitor of NF-κB activation. This study demonstrates that curcumin effectively suppresses NF-κB activation induced by various stimuli, including tumor necrosis factor (TNF), phorbol ester, and hydrogen peroxide. NF-κB is a critical transcription factor involved in immune responses and inflammatory processes. Curcumin inhibits NF-κB activation at a step before IκBα phosphorylation but after the convergence of various signals. It does not affect the Sp1 transcription factor but down-regulates AP-1 binding factors. The mechanism of curcumin's action differs from that of protein tyrosine phosphatase inhibitors. Curcumin prevents the degradation of IκBα and the nuclear translocation of the p65 subunit of NF-κB. These findings suggest that curcumin could be a potential therapeutic agent for modulating NF-κB-dependent pathological conditions. The study also shows that curcumin's inhibitory effects are not reversed by reducing agents like DTT or DMP, indicating a distinct mechanism of action. Overall, curcumin's ability to inhibit NF-κB activation makes it a promising candidate for the treatment of diseases associated with NF-κB dysregulation.Curcumin, a compound derived from turmeric, is a potent inhibitor of NF-κB activation. This study demonstrates that curcumin effectively suppresses NF-κB activation induced by various stimuli, including tumor necrosis factor (TNF), phorbol ester, and hydrogen peroxide. NF-κB is a critical transcription factor involved in immune responses and inflammatory processes. Curcumin inhibits NF-κB activation at a step before IκBα phosphorylation but after the convergence of various signals. It does not affect the Sp1 transcription factor but down-regulates AP-1 binding factors. The mechanism of curcumin's action differs from that of protein tyrosine phosphatase inhibitors. Curcumin prevents the degradation of IκBα and the nuclear translocation of the p65 subunit of NF-κB. These findings suggest that curcumin could be a potential therapeutic agent for modulating NF-κB-dependent pathological conditions. The study also shows that curcumin's inhibitory effects are not reversed by reducing agents like DTT or DMP, indicating a distinct mechanism of action. Overall, curcumin's ability to inhibit NF-κB activation makes it a promising candidate for the treatment of diseases associated with NF-κB dysregulation.